We propose a new L2‐type goodness‐of‐fit test for the family of beta distributions based on a conditional moment characterization. The asymptotic null distribution is identified, and since it depends on the underlying parameters, a parametric bootstrap procedure is proposed. Consistency against all alternatives that satisfy a convergence criterion is shown, and a Monte Carlo simulation study indicates that the new procedure outperforms most of the classical tests. Finally, the procedure is applied to a real data set related to air humidity.
We propose a new L 2 -type goodness-of-fit test for the family of beta distributions based on a conditional moment characterisation. The asymptotic null distribution is identified, and since it depends on the underlying parameters, a parametric bootstrap procedure is proposed. Consistency against all alternatives that satisfy a convergence criterion is shown, and a Monte Carlo simulation study indicates that the new procedure outperforms most of the classical tests. Finally, the procedure is applied to a real data set related to air humidity.
The Rayleigh distribution has recently become popular as a model for a range of phenomena. As a result, a number of goodness-of-fit tests have been developed for this distribution. In this paper, we provide the first overview of goodness-of-fit tests for the Rayleigh distribution and compare these tests in a Monte-Carlo study to identify the tests that provide the highest powers against a wide range of alternatives. Our findings suggest that two recently developed tests as well as a test based on the Laplace transform and a test based on the Hellinger distance are the better performing tests.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.